1![Corporate Presentation January 2016 A world-class specialty biopharma business Corporate Presentation January 2016 A world-class specialty biopharma business](https://www.pdfsearch.io/img/b52f5331e5e2b513ef68f72af607b5a5.jpg) | Add to Reading ListSource URL: www.circassia.comLanguage: English - Date: 2016-01-11 11:48:32
|
---|
2![ORALAIR® is a registered trademark of Stallergenes SA and marketed by Stallergenes Canada Inc.
PRODUCT MONOGRAPH Pr ORALAIR® is a registered trademark of Stallergenes SA and marketed by Stallergenes Canada Inc.
PRODUCT MONOGRAPH Pr](https://www.pdfsearch.io/img/8668a2ab23933ea71c55f28e42025967.jpg) | Add to Reading ListSource URL: www.stallergenes.caLanguage: English - Date: 2015-06-12 13:15:16
|
---|
3![Microsoft Word - ActoGeniX-Stallergenes Press Release ENGdef Microsoft Word - ActoGeniX-Stallergenes Press Release ENGdef](https://www.pdfsearch.io/img/bc3502cce1140ac7276da63413babcdd.jpg) | Add to Reading ListSource URL: www.actogenix.comLanguage: English - Date: 2014-11-20 05:36:21
|
---|
4![Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol](https://www.pdfsearch.io/img/33fbecc944ef6a306aaab1daaef2b18c.jpg) | Add to Reading ListSource URL: www.ctajournal.comLanguage: English |
---|
5![Clinical and Molecular Allergy.eps Clinical and Molecular Allergy.eps](https://www.pdfsearch.io/img/94529d6b7e3c73054ebb4e84963f017c.jpg) | Add to Reading ListSource URL: www.clinicalmolecularallergy.comLanguage: English |
---|
6![leaflet_acariens_7244V3.pdf leaflet_acariens_7244V3.pdf](https://www.pdfsearch.io/img/77eebdeda95d6f9ef11f2c2376afc322.jpg) | Add to Reading ListSource URL: www.stallergenes.frLanguage: French - Date: 2014-10-21 05:00:26
|
---|
7![Stallergenes worldwide HEADQUARTERS STALLERGENES 6, rue Alexis de Tocqueville CSAntony Cedex Tel.: +00 Stallergenes worldwide HEADQUARTERS STALLERGENES 6, rue Alexis de Tocqueville CSAntony Cedex Tel.: +00](https://www.pdfsearch.io/img/26412e599f4b99c13b6bbbc49953f5a3.jpg) | Add to Reading ListSource URL: www.stallergenes.frLanguage: English - Date: 2015-02-26 11:16:17
|
---|
8![leaflet_arbres_7210V5.pdf leaflet_arbres_7210V5.pdf](https://www.pdfsearch.io/img/cc3aef6fe99811272df95afd1cabefaa.jpg) | Add to Reading ListSource URL: www.stallergenes.frLanguage: French - Date: 2014-10-21 05:00:27
|
---|
9![Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of patients with mild asthma Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of patients with mild asthma](https://www.pdfsearch.io/img/52dcdee5de960181c23e27f40ec33bd8.jpg) | Add to Reading ListSource URL: www.worldallergy.orgLanguage: English - Date: 2015-01-12 13:25:07
|
---|
10![19 May 2014 EMA[removed]Patient Health Protection Organisation funding sources NAME OF ORGANISATION: European Federation of Allergy and Airways Diseases Patients’ Associations EFA 19 May 2014 EMA[removed]Patient Health Protection Organisation funding sources NAME OF ORGANISATION: European Federation of Allergy and Airways Diseases Patients’ Associations EFA](https://www.pdfsearch.io/img/9919da9a80963bb430d2bfd5dca104a1.jpg) | Add to Reading ListSource URL: www.efanet.orgLanguage: English - Date: 2014-10-06 07:14:41
|
---|